Antepartum continuous epidural ropivacaine therapy reduces uterine artery vascular resistance in pre-eclampsia: A randomized, dose-ranging, placebo-controlled study

  • Y. Ginosar
  • , M. Nadjari
  • , A. Hoffman
  • , N. Firman
  • , E. M. Davidson
  • , C. F. Weiniger
  • , L. Rosen
  • , C. Weissman
  • , U. Elchalal
  • , A. Avidan
  • , Y. Golob
  • , E. Y. Anteby
  • , Y. Ezra
  • , D. Hochner-Celnikier
  • , D. D. Mankuta
  • , S. Yagel
  • , L. Kleinberg
  • , S. Haroutinian
  • , B. Bar-Oz
  • , H. Kaniel
    • N. Novick, S. H. Halpern

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Antepartum continuous epidural ropivacaine therapy reduces uterine artery vascular resistance in pre-eclampsia: A randomized, dose-ranging, placebo-controlled study'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science